Oncology Institute Inc (TOI) - Total Liabilities
Based on the latest financial reports, Oncology Institute Inc (TOI) has total liabilities worth $184.51 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Oncology Institute Inc growing its equity to track the company's year-over-year net asset growth rate.
Oncology Institute Inc - Total Liabilities Trend (2019–2025)
This chart illustrates how Oncology Institute Inc's total liabilities have evolved over time, based on quarterly financial data. See TOI free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Oncology Institute Inc Competitors by Total Liabilities
The table below lists competitors of Oncology Institute Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Freegold Ventures Limited
TO:FVL
|
Canada | CA$1.03 Million |
|
Fujian Minfa Aluminium Co Ltd
SHE:002578
|
China | CN¥737.45 Million |
|
Jerusalem
TA:JBNK
|
Israel | ILA21.45 Billion |
|
Guangdong VTR Bio-Tech Co Ltd
SHE:300381
|
China | CN¥266.84 Million |
|
International Money Express Inc
NASDAQ:IMXI
|
USA | $261.42 Million |
|
Grand Korea Leisure Co. Ltd
KO:114090
|
Korea | ₩206.86 Billion |
|
Malaysia Smelting Corporation Bhd
KLSE:5916
|
Malaysia | RM709.11 Million |
|
Einhell Germany AG
F:EIN
|
Germany | €466.55 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Oncology Institute Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Oncology Institute Inc market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -11.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Oncology Institute Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Oncology Institute Inc (2019–2025)
The table below shows the annual total liabilities of Oncology Institute Inc from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $180.38 Million | +6.65% |
| 2024-12-31 | $169.13 Million | +11.11% |
| 2023-12-31 | $152.22 Million | +9.91% |
| 2022-12-31 | $138.49 Million | +39.49% |
| 2021-12-31 | $99.28 Million | +164.13% |
| 2020-12-31 | $37.59 Million | +117.29% |
| 2019-12-31 | $17.30 Million | -- |
About Oncology Institute Inc
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as edu… Read more